CAV1 and Hyperglycemia: Secondly, post-stroke hyperglycemia reduces ZO-1 expression through a dual mechanism (1): promoting Cav-1-mediated translocation of ZO-1 from the BMEC membrane to the cytoplasm, and (2) increasing autolysosomal degradation of ZO-1 (76).